Side-by-side financials for BON and DFTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BON | DFTX |
|---|---|---|
| Market cap | - | $2.53 B |
| US-listed rank | - | #1936 |
| Revenue (latest FY) | $18.67M | - |
| Net income (latest FY) | -$1.99M | -$183.79M |
| Net margin | -10.7% | - |
| SEC filings | 151 | 445 |
Full pages: Bon Natural Life Ltd and Definium Therapeutics, Inc., or browse the full rankings.